Histotripsy: Minimally Invasive Technology for Prostatic Tissue Ablation in an In Vivo Canine Model
Objectives Symptoms of benign prostatic hyperplasia affect men increasingly as they age. Minimally invasive therapies for the treatment of benign prostatic hyperplasia continue to evolve. We describe histotripsy, a noninvasive, nonthermal, focused ultrasound technology for precise tissue ablation, a...
Gespeichert in:
Veröffentlicht in: | Urology (Ridgewood, N.J.) N.J.), 2008-09, Vol.72 (3), p.682-686 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 686 |
---|---|
container_issue | 3 |
container_start_page | 682 |
container_title | Urology (Ridgewood, N.J.) |
container_volume | 72 |
creator | Lake, Alison M Hall, Timothy L Kieran, Kathleen Fowlkes, J. Brian Cain, Charles A Roberts, William W |
description | Objectives Symptoms of benign prostatic hyperplasia affect men increasingly as they age. Minimally invasive therapies for the treatment of benign prostatic hyperplasia continue to evolve. We describe histotripsy, a noninvasive, nonthermal, focused ultrasound technology for precise tissue ablation, and report the initial results of using histotripsy for prostatic tissue ablation in an in vivo canine model. Methods An annular 18-element, 750-kHz, phased-array ultrasound system delivered high-intensity (22 kW/cm2 ), ultrasound pulses (15 cycles in 20 ms) at pulse repetition frequencies of 100 to 500 Hz to canine prostates. Eight lateral lobe and nine periurethral treatments were performed in 11 anesthetized dogs. Diagnostic ultrasound transducers provided in-line and transrectal imaging. Retrograde urethrography was performed before and after the periurethral treatments. After treatment, the prostates were grossly examined, sectioned, and submitted for histologic examination. Results In the lateral lobe treatments, a well-demarcated cavity containing liquefied material was present at the ablation site. Microscopically, the targeted volume was characterized by the presence of histotripsy paste (debris, absent cellular structures). A narrow margin of cellular injury was noted, beyond which no tissue damage was apparent. The periurethral treatments resulted in total urethral ablation or significant urethral wall damage, with visible prostatic urethral defects on retrograde urethrography. Real-time ultrasound imaging demonstrated a dynamic hyperechoic zone at the focus, indicative of cavitation and suggesting effective tissue ablation. Conclusions The results of our study have shown that histotripsy is capable of precise prostatic tissue destruction and results in subcellular fractionation of prostate parenchyma. Histotripsy can also produce prostatic urethral damage and thereby facilitate drainage of finely fractionated material per urethra, producing immediate debulking. |
doi_str_mv | 10.1016/j.urology.2008.01.037 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69492788</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0090429508001064</els_id><sourcerecordid>69492788</sourcerecordid><originalsourceid>FETCH-LOGICAL-c561t-4bffcc4c02c3a2006e206c631e457f11df2057bde46d66fe5b1983e06c9942193</originalsourceid><addsrcrecordid>eNqFkkFv1DAQhS0EokvhJ4B8gVvC2EmcmAOoWgGt1AokFq6W40zAS9be2slK-fc4bAQSF06Wrfdm5n0eQp4zyBkw8XqfT8EP_vucc4AmB5ZDUT8gG1bxOpNSVg_JBkBCVnJZXZAnMe4BQAhRPyYXrCnSM2s2xFzbOPox2GOc39A76-xBD8NMb9xJR3tCukPzw_1uRHsf6Ofg46hHa-jOxjghvWqHdPWOWke1Sz76zZ483WpnHdI73-HwlDzq9RDx2Xpekq8f3u-219ntp48326vbzFSCjVnZ9r0xpQFuCp1CCeQgjCgYllXdM9b1HKq67bAUnRA9Vi2TTYFJI2XJmSwuyatz3WPw9xPGUR1sNDgM2qGfohKylLxumiSszkKT0sSAvTqGlDvMioFa6Kq9Wumqha4CphLd5HuxNpjaA3Z_XSvOJHi5CnQ0euiDdsbGP7qUpyp4vUz67qzDhONkMahoLDqDnQ1oRtV5-99R3v5TwQzp81LTnzhj3PspuMRaMRW5AvVlWYVlE6ABYCDK4he-n7Br</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69492788</pqid></control><display><type>article</type><title>Histotripsy: Minimally Invasive Technology for Prostatic Tissue Ablation in an In Vivo Canine Model</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Lake, Alison M ; Hall, Timothy L ; Kieran, Kathleen ; Fowlkes, J. Brian ; Cain, Charles A ; Roberts, William W</creator><creatorcontrib>Lake, Alison M ; Hall, Timothy L ; Kieran, Kathleen ; Fowlkes, J. Brian ; Cain, Charles A ; Roberts, William W</creatorcontrib><description>Objectives Symptoms of benign prostatic hyperplasia affect men increasingly as they age. Minimally invasive therapies for the treatment of benign prostatic hyperplasia continue to evolve. We describe histotripsy, a noninvasive, nonthermal, focused ultrasound technology for precise tissue ablation, and report the initial results of using histotripsy for prostatic tissue ablation in an in vivo canine model. Methods An annular 18-element, 750-kHz, phased-array ultrasound system delivered high-intensity (22 kW/cm2 ), ultrasound pulses (15 cycles in 20 ms) at pulse repetition frequencies of 100 to 500 Hz to canine prostates. Eight lateral lobe and nine periurethral treatments were performed in 11 anesthetized dogs. Diagnostic ultrasound transducers provided in-line and transrectal imaging. Retrograde urethrography was performed before and after the periurethral treatments. After treatment, the prostates were grossly examined, sectioned, and submitted for histologic examination. Results In the lateral lobe treatments, a well-demarcated cavity containing liquefied material was present at the ablation site. Microscopically, the targeted volume was characterized by the presence of histotripsy paste (debris, absent cellular structures). A narrow margin of cellular injury was noted, beyond which no tissue damage was apparent. The periurethral treatments resulted in total urethral ablation or significant urethral wall damage, with visible prostatic urethral defects on retrograde urethrography. Real-time ultrasound imaging demonstrated a dynamic hyperechoic zone at the focus, indicative of cavitation and suggesting effective tissue ablation. Conclusions The results of our study have shown that histotripsy is capable of precise prostatic tissue destruction and results in subcellular fractionation of prostate parenchyma. Histotripsy can also produce prostatic urethral damage and thereby facilitate drainage of finely fractionated material per urethra, producing immediate debulking.</description><identifier>ISSN: 0090-4295</identifier><identifier>EISSN: 1527-9995</identifier><identifier>DOI: 10.1016/j.urology.2008.01.037</identifier><identifier>PMID: 18342918</identifier><identifier>CODEN: URGYAZ</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Animals ; Biological and medical sciences ; Disease Models, Animal ; Dogs ; Equipment Design ; Humans ; Male ; Medical sciences ; Nephrology. Urinary tract diseases ; Prostate - metabolism ; Prostate - pathology ; Prostatic Hyperplasia - diagnosis ; Prostatic Hyperplasia - therapy ; Subcellular Fractions ; Ultrasonic Therapy ; Ultrasound, High-Intensity Focused, Transrectal - instrumentation ; Ultrasound, High-Intensity Focused, Transrectal - methods ; Urology</subject><ispartof>Urology (Ridgewood, N.J.), 2008-09, Vol.72 (3), p.682-686</ispartof><rights>Elsevier Inc.</rights><rights>2008 Elsevier Inc.</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c561t-4bffcc4c02c3a2006e206c631e457f11df2057bde46d66fe5b1983e06c9942193</citedby><cites>FETCH-LOGICAL-c561t-4bffcc4c02c3a2006e206c631e457f11df2057bde46d66fe5b1983e06c9942193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0090429508001064$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20653279$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18342918$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lake, Alison M</creatorcontrib><creatorcontrib>Hall, Timothy L</creatorcontrib><creatorcontrib>Kieran, Kathleen</creatorcontrib><creatorcontrib>Fowlkes, J. Brian</creatorcontrib><creatorcontrib>Cain, Charles A</creatorcontrib><creatorcontrib>Roberts, William W</creatorcontrib><title>Histotripsy: Minimally Invasive Technology for Prostatic Tissue Ablation in an In Vivo Canine Model</title><title>Urology (Ridgewood, N.J.)</title><addtitle>Urology</addtitle><description>Objectives Symptoms of benign prostatic hyperplasia affect men increasingly as they age. Minimally invasive therapies for the treatment of benign prostatic hyperplasia continue to evolve. We describe histotripsy, a noninvasive, nonthermal, focused ultrasound technology for precise tissue ablation, and report the initial results of using histotripsy for prostatic tissue ablation in an in vivo canine model. Methods An annular 18-element, 750-kHz, phased-array ultrasound system delivered high-intensity (22 kW/cm2 ), ultrasound pulses (15 cycles in 20 ms) at pulse repetition frequencies of 100 to 500 Hz to canine prostates. Eight lateral lobe and nine periurethral treatments were performed in 11 anesthetized dogs. Diagnostic ultrasound transducers provided in-line and transrectal imaging. Retrograde urethrography was performed before and after the periurethral treatments. After treatment, the prostates were grossly examined, sectioned, and submitted for histologic examination. Results In the lateral lobe treatments, a well-demarcated cavity containing liquefied material was present at the ablation site. Microscopically, the targeted volume was characterized by the presence of histotripsy paste (debris, absent cellular structures). A narrow margin of cellular injury was noted, beyond which no tissue damage was apparent. The periurethral treatments resulted in total urethral ablation or significant urethral wall damage, with visible prostatic urethral defects on retrograde urethrography. Real-time ultrasound imaging demonstrated a dynamic hyperechoic zone at the focus, indicative of cavitation and suggesting effective tissue ablation. Conclusions The results of our study have shown that histotripsy is capable of precise prostatic tissue destruction and results in subcellular fractionation of prostate parenchyma. Histotripsy can also produce prostatic urethral damage and thereby facilitate drainage of finely fractionated material per urethra, producing immediate debulking.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Disease Models, Animal</subject><subject>Dogs</subject><subject>Equipment Design</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Prostate - metabolism</subject><subject>Prostate - pathology</subject><subject>Prostatic Hyperplasia - diagnosis</subject><subject>Prostatic Hyperplasia - therapy</subject><subject>Subcellular Fractions</subject><subject>Ultrasonic Therapy</subject><subject>Ultrasound, High-Intensity Focused, Transrectal - instrumentation</subject><subject>Ultrasound, High-Intensity Focused, Transrectal - methods</subject><subject>Urology</subject><issn>0090-4295</issn><issn>1527-9995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkkFv1DAQhS0EokvhJ4B8gVvC2EmcmAOoWgGt1AokFq6W40zAS9be2slK-fc4bAQSF06Wrfdm5n0eQp4zyBkw8XqfT8EP_vucc4AmB5ZDUT8gG1bxOpNSVg_JBkBCVnJZXZAnMe4BQAhRPyYXrCnSM2s2xFzbOPox2GOc39A76-xBD8NMb9xJR3tCukPzw_1uRHsf6Ofg46hHa-jOxjghvWqHdPWOWke1Sz76zZ483WpnHdI73-HwlDzq9RDx2Xpekq8f3u-219ntp48326vbzFSCjVnZ9r0xpQFuCp1CCeQgjCgYllXdM9b1HKq67bAUnRA9Vi2TTYFJI2XJmSwuyatz3WPw9xPGUR1sNDgM2qGfohKylLxumiSszkKT0sSAvTqGlDvMioFa6Kq9Wumqha4CphLd5HuxNpjaA3Z_XSvOJHi5CnQ0euiDdsbGP7qUpyp4vUz67qzDhONkMahoLDqDnQ1oRtV5-99R3v5TwQzp81LTnzhj3PspuMRaMRW5AvVlWYVlE6ABYCDK4he-n7Br</recordid><startdate>20080901</startdate><enddate>20080901</enddate><creator>Lake, Alison M</creator><creator>Hall, Timothy L</creator><creator>Kieran, Kathleen</creator><creator>Fowlkes, J. Brian</creator><creator>Cain, Charles A</creator><creator>Roberts, William W</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080901</creationdate><title>Histotripsy: Minimally Invasive Technology for Prostatic Tissue Ablation in an In Vivo Canine Model</title><author>Lake, Alison M ; Hall, Timothy L ; Kieran, Kathleen ; Fowlkes, J. Brian ; Cain, Charles A ; Roberts, William W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c561t-4bffcc4c02c3a2006e206c631e457f11df2057bde46d66fe5b1983e06c9942193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Disease Models, Animal</topic><topic>Dogs</topic><topic>Equipment Design</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Prostate - metabolism</topic><topic>Prostate - pathology</topic><topic>Prostatic Hyperplasia - diagnosis</topic><topic>Prostatic Hyperplasia - therapy</topic><topic>Subcellular Fractions</topic><topic>Ultrasonic Therapy</topic><topic>Ultrasound, High-Intensity Focused, Transrectal - instrumentation</topic><topic>Ultrasound, High-Intensity Focused, Transrectal - methods</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lake, Alison M</creatorcontrib><creatorcontrib>Hall, Timothy L</creatorcontrib><creatorcontrib>Kieran, Kathleen</creatorcontrib><creatorcontrib>Fowlkes, J. Brian</creatorcontrib><creatorcontrib>Cain, Charles A</creatorcontrib><creatorcontrib>Roberts, William W</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Urology (Ridgewood, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lake, Alison M</au><au>Hall, Timothy L</au><au>Kieran, Kathleen</au><au>Fowlkes, J. Brian</au><au>Cain, Charles A</au><au>Roberts, William W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Histotripsy: Minimally Invasive Technology for Prostatic Tissue Ablation in an In Vivo Canine Model</atitle><jtitle>Urology (Ridgewood, N.J.)</jtitle><addtitle>Urology</addtitle><date>2008-09-01</date><risdate>2008</risdate><volume>72</volume><issue>3</issue><spage>682</spage><epage>686</epage><pages>682-686</pages><issn>0090-4295</issn><eissn>1527-9995</eissn><coden>URGYAZ</coden><abstract>Objectives Symptoms of benign prostatic hyperplasia affect men increasingly as they age. Minimally invasive therapies for the treatment of benign prostatic hyperplasia continue to evolve. We describe histotripsy, a noninvasive, nonthermal, focused ultrasound technology for precise tissue ablation, and report the initial results of using histotripsy for prostatic tissue ablation in an in vivo canine model. Methods An annular 18-element, 750-kHz, phased-array ultrasound system delivered high-intensity (22 kW/cm2 ), ultrasound pulses (15 cycles in 20 ms) at pulse repetition frequencies of 100 to 500 Hz to canine prostates. Eight lateral lobe and nine periurethral treatments were performed in 11 anesthetized dogs. Diagnostic ultrasound transducers provided in-line and transrectal imaging. Retrograde urethrography was performed before and after the periurethral treatments. After treatment, the prostates were grossly examined, sectioned, and submitted for histologic examination. Results In the lateral lobe treatments, a well-demarcated cavity containing liquefied material was present at the ablation site. Microscopically, the targeted volume was characterized by the presence of histotripsy paste (debris, absent cellular structures). A narrow margin of cellular injury was noted, beyond which no tissue damage was apparent. The periurethral treatments resulted in total urethral ablation or significant urethral wall damage, with visible prostatic urethral defects on retrograde urethrography. Real-time ultrasound imaging demonstrated a dynamic hyperechoic zone at the focus, indicative of cavitation and suggesting effective tissue ablation. Conclusions The results of our study have shown that histotripsy is capable of precise prostatic tissue destruction and results in subcellular fractionation of prostate parenchyma. Histotripsy can also produce prostatic urethral damage and thereby facilitate drainage of finely fractionated material per urethra, producing immediate debulking.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>18342918</pmid><doi>10.1016/j.urology.2008.01.037</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0090-4295 |
ispartof | Urology (Ridgewood, N.J.), 2008-09, Vol.72 (3), p.682-686 |
issn | 0090-4295 1527-9995 |
language | eng |
recordid | cdi_proquest_miscellaneous_69492788 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Animals Biological and medical sciences Disease Models, Animal Dogs Equipment Design Humans Male Medical sciences Nephrology. Urinary tract diseases Prostate - metabolism Prostate - pathology Prostatic Hyperplasia - diagnosis Prostatic Hyperplasia - therapy Subcellular Fractions Ultrasonic Therapy Ultrasound, High-Intensity Focused, Transrectal - instrumentation Ultrasound, High-Intensity Focused, Transrectal - methods Urology |
title | Histotripsy: Minimally Invasive Technology for Prostatic Tissue Ablation in an In Vivo Canine Model |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T12%3A54%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Histotripsy:%20Minimally%20Invasive%20Technology%20for%20Prostatic%20Tissue%20Ablation%20in%20an%20In%20Vivo%20Canine%20Model&rft.jtitle=Urology%20(Ridgewood,%20N.J.)&rft.au=Lake,%20Alison%20M&rft.date=2008-09-01&rft.volume=72&rft.issue=3&rft.spage=682&rft.epage=686&rft.pages=682-686&rft.issn=0090-4295&rft.eissn=1527-9995&rft.coden=URGYAZ&rft_id=info:doi/10.1016/j.urology.2008.01.037&rft_dat=%3Cproquest_cross%3E69492788%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69492788&rft_id=info:pmid/18342918&rft_els_id=S0090429508001064&rfr_iscdi=true |